The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes
British Journal of Haematology · 2026-11 · 209 (5) · 2335-2340
DOI: 10.1111/bjh.70778 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 26.08.2026. Verfasst von George Vrachiolias und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Haematology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
- Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
- Gustave Roussy, Villejuif, France.
- Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: George Vrachiolias, Athanasios Tasis, Theodoros Spyropoulos, Despoina Dimitriou, Christina Misidou, Konstantinos Liapis, Emmanouil Spanoudakis, Maria Koffa, Iliana Stamatiou, Elsa Bernard, Ioannis Mitroulis
Zitieren
APA
Vrachiolias, G., Lamprianidou, E., Tasis, A., Spyropoulos, T., Dimitriou, D., Kymparidou, C., Misidou, C., Liapis, K., Spanoudakis, E., Koffa, M., Papoutselis, M., Stamatiou, I., Bernard, E., Papaemmanuil, E., Mitroulis, I., & Kotsianidis, I. (2026). The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes. British Journal of Haematology, 209(5), 2335-2340. https://doi.org/10.1111/bjh.70778
Vancouver
Vrachiolias G, Lamprianidou E, Tasis A, Spyropoulos T, Dimitriou D, Kymparidou C, et al. The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes. British Journal of Haematology. 2026;209(5):2335-2340. doi:10.1111/bjh.70778
BibTeX
@article{Vrachiolias2026,
author = {Vrachiolias, George and Lamprianidou, Eleftheria and Tasis, Athanasios and Spyropoulos, Theodoros and Dimitriou, Despoina and Kymparidou, Chryssa and Misidou, Christina and Liapis, Konstantinos and Spanoudakis, Emmanouil and Koffa, Maria and Papoutselis, Menelaos and Stamatiou, Iliana and Bernard, Elsa and Papaemmanuil, Elli and Mitroulis, Ioannis and Kotsianidis, Ioannis},
title = {The role of the adenosinergic pathway in resistance to hypomethylating agents in patients with high‐risk myelodysplastic syndromes},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {5},
pages = {2335--2340},
doi = {10.1111/bjh.70778}
}
EUVIMED